CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.
Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Market Analysis and Insights: Global CRISPR & Cas Genes Market
The global CRISPR & Cas Genes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR & Cas Genes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR & Cas Genes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR & Cas Genes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR & Cas Genes market.
CRISPR & Cas Genes Breakdown Data by Type
Vector-based Cas
DNA-free Cas
Cell Line Engineering
CRISPR & Cas Genes Breakdown Data by Application
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Based on regional and country-level analysis, the CRISPR & Cas Genes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR & Cas Genes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
Cibus
Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Market Analysis and Insights: Global CRISPR & Cas Genes Market
The global CRISPR & Cas Genes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR & Cas Genes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR & Cas Genes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR & Cas Genes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR & Cas Genes market.
CRISPR & Cas Genes Breakdown Data by Type
Vector-based Cas
DNA-free Cas
Cell Line Engineering
CRISPR & Cas Genes Breakdown Data by Application
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Based on regional and country-level analysis, the CRISPR & Cas Genes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR & Cas Genes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
Cibus
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Vector-based Cas
1.2.3 DNA-free Cas
1.2.4 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2026
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academics and Government Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas Genes Market Perspective (2015-2026)
2.2 Global CRISPR & Cas Genes Growth Trends by Regions
2.2.1 CRISPR & Cas Genes Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas Genes Players by Market Size
3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2015-2020)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2015-2020)
3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue
3.4 Global CRISPR & Cas Genes Market Concentration Ratio
3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2019
3.5 Key Players CRISPR & Cas Genes Area Served
3.6 Key Players CRISPR & Cas Genes Product Solution and Service
3.7 Date of Enter into CRISPR & Cas Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas Genes Breakdown Data by Type (2015-2026)
4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2015-2020)
4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2021-2026)
5 CRISPR & Cas Genes Breakdown Data by Application (2015-2026)
5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2015-2020)
5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR & Cas Genes Market Size (2015-2026)
6.2 North America CRISPR & Cas Genes Market Size by Type (2015-2020)
6.3 North America CRISPR & Cas Genes Market Size by Application (2015-2020)
6.4 North America CRISPR & Cas Genes Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CRISPR & Cas Genes Market Size (2015-2026)
7.2 Europe CRISPR & Cas Genes Market Size by Type (2015-2020)
7.3 Europe CRISPR & Cas Genes Market Size by Application (2015-2020)
7.4 Europe CRISPR & Cas Genes Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CRISPR & Cas Genes Market Size (2015-2026)
8.2 China CRISPR & Cas Genes Market Size by Type (2015-2020)
8.3 China CRISPR & Cas Genes Market Size by Application (2015-2020)
8.4 China CRISPR & Cas Genes Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CRISPR & Cas Genes Market Size (2015-2026)
9.2 Japan CRISPR & Cas Genes Market Size by Type (2015-2020)
9.3 Japan CRISPR & Cas Genes Market Size by Application (2015-2020)
9.4 Japan CRISPR & Cas Genes Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CRISPR & Cas Genes Market Size (2015-2026)
10.2 Southeast Asia CRISPR & Cas Genes Market Size by Type (2015-2020)
10.3 Southeast Asia CRISPR & Cas Genes Market Size by Application (2015-2020)
10.4 Southeast Asia CRISPR & Cas Genes Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction
11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2015-2020))
11.1.5 CRISPR Therapeutics Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca CRISPR & Cas Genes Introduction
11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2015-2020)
11.2.5 AstraZeneca Recent Development
11.3 Addgene
11.3.1 Addgene Company Details
11.3.2 Addgene Business Overview
11.3.3 Addgene CRISPR & Cas Genes Introduction
11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2015-2020)
11.3.5 Addgene Recent Development
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Details
11.4.2 Caribou Biosciences, Inc. Business Overview
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction
11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.4.5 Caribou Biosciences, Inc. Recent Development
11.5 Cellectis
11.5.1 Cellectis Company Details
11.5.2 Cellectis Business Overview
11.5.3 Cellectis CRISPR & Cas Genes Introduction
11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.5.5 Cellectis Recent Development
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Details
11.6.2 Editas Medicine, Inc. Business Overview
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction
11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.6.5 Editas Medicine, Inc. Recent Development
11.7 Egenesis
11.7.1 Egenesis Company Details
11.7.2 Egenesis Business Overview
11.7.3 Egenesis CRISPR & Cas Genes Introduction
11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.7.5 Egenesis Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Details
11.9.2 Horizon Discovery Group Plc Business Overview
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction
11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2015-2020)
11.9.5 Horizon Discovery Group Plc Recent Development
11.10 Genscrip
11.10.1 Genscrip Company Details
11.10.2 Genscrip Business Overview
11.10.3 Genscrip CRISPR & Cas Genes Introduction
11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2015-2020)
11.10.5 Genscrip Recent Development
11.11 Danaher Corporation
10.11.1 Danaher Corporation Company Details
10.11.2 Danaher Corporation Business Overview
10.11.3 Danaher Corporation CRISPR & Cas Genes Introduction
10.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2015-2020)
10.11.5 Danaher Corporation Recent Development
11.12 Intellia Therapeutics, Inc.
10.12.1 Intellia Therapeutics, Inc. Company Details
10.12.2 Intellia Therapeutics, Inc. Business Overview
10.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction
10.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 Lonza
10.13.1 Lonza Company Details
10.13.2 Lonza Business Overview
10.13.3 Lonza CRISPR & Cas Genes Introduction
10.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2015-2020)
10.13.5 Lonza Recent Development
11.14 Merck KGaA
10.14.1 Merck KGaA Company Details
10.14.2 Merck KGaA Business Overview
10.14.3 Merck KGaA CRISPR & Cas Genes Introduction
10.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2015-2020)
10.14.5 Merck KGaA Recent Development
11.15 New England BioLabs
10.15.1 New England BioLabs Company Details
10.15.2 New England BioLabs Business Overview
10.15.3 New England BioLabs CRISPR & Cas Genes Introduction
10.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2015-2020)
10.15.5 New England BioLabs Recent Development
11.16 Takara Bio, Inc.
10.16.1 Takara Bio, Inc. Company Details
10.16.2 Takara Bio, Inc. Business Overview
10.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction
10.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.16.5 Takara Bio, Inc. Recent Development
11.17 Synthego
10.17.1 Synthego Company Details
10.17.2 Synthego Business Overview
10.17.3 Synthego CRISPR & Cas Genes Introduction
10.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2015-2020)
10.17.5 Synthego Recent Development
11.18 Mammoth Biosciences
10.18.1 Mammoth Biosciences Company Details
10.18.2 Mammoth Biosciences Business Overview
10.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction
10.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2015-2020)
10.18.5 Mammoth Biosciences Recent Development
11.19 Inscripta, Inc.
10.19.1 Inscripta, Inc. Company Details
10.19.2 Inscripta, Inc. Business Overview
10.19.3 Inscripta, Inc. CRISPR & Cas Genes Introduction
10.19.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.19.5 Inscripta, Inc. Recent Development
11.20 Cibus
10.20.1 Cibus Company Details
10.20.2 Cibus Business Overview
10.20.3 Cibus CRISPR & Cas Genes Introduction
10.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2015-2020)
10.20.5 Cibus Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Vector-based Cas
1.2.3 DNA-free Cas
1.2.4 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2026
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academics and Government Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas Genes Market Perspective (2015-2026)
2.2 Global CRISPR & Cas Genes Growth Trends by Regions
2.2.1 CRISPR & Cas Genes Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas Genes Players by Market Size
3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2015-2020)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2015-2020)
3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue
3.4 Global CRISPR & Cas Genes Market Concentration Ratio
3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2019
3.5 Key Players CRISPR & Cas Genes Area Served
3.6 Key Players CRISPR & Cas Genes Product Solution and Service
3.7 Date of Enter into CRISPR & Cas Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas Genes Breakdown Data by Type (2015-2026)
4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2015-2020)
4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2021-2026)
5 CRISPR & Cas Genes Breakdown Data by Application (2015-2026)
5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2015-2020)
5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR & Cas Genes Market Size (2015-2026)
6.2 North America CRISPR & Cas Genes Market Size by Type (2015-2020)
6.3 North America CRISPR & Cas Genes Market Size by Application (2015-2020)
6.4 North America CRISPR & Cas Genes Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CRISPR & Cas Genes Market Size (2015-2026)
7.2 Europe CRISPR & Cas Genes Market Size by Type (2015-2020)
7.3 Europe CRISPR & Cas Genes Market Size by Application (2015-2020)
7.4 Europe CRISPR & Cas Genes Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CRISPR & Cas Genes Market Size (2015-2026)
8.2 China CRISPR & Cas Genes Market Size by Type (2015-2020)
8.3 China CRISPR & Cas Genes Market Size by Application (2015-2020)
8.4 China CRISPR & Cas Genes Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CRISPR & Cas Genes Market Size (2015-2026)
9.2 Japan CRISPR & Cas Genes Market Size by Type (2015-2020)
9.3 Japan CRISPR & Cas Genes Market Size by Application (2015-2020)
9.4 Japan CRISPR & Cas Genes Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CRISPR & Cas Genes Market Size (2015-2026)
10.2 Southeast Asia CRISPR & Cas Genes Market Size by Type (2015-2020)
10.3 Southeast Asia CRISPR & Cas Genes Market Size by Application (2015-2020)
10.4 Southeast Asia CRISPR & Cas Genes Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction
11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2015-2020))
11.1.5 CRISPR Therapeutics Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca CRISPR & Cas Genes Introduction
11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2015-2020)
11.2.5 AstraZeneca Recent Development
11.3 Addgene
11.3.1 Addgene Company Details
11.3.2 Addgene Business Overview
11.3.3 Addgene CRISPR & Cas Genes Introduction
11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2015-2020)
11.3.5 Addgene Recent Development
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Details
11.4.2 Caribou Biosciences, Inc. Business Overview
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction
11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.4.5 Caribou Biosciences, Inc. Recent Development
11.5 Cellectis
11.5.1 Cellectis Company Details
11.5.2 Cellectis Business Overview
11.5.3 Cellectis CRISPR & Cas Genes Introduction
11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.5.5 Cellectis Recent Development
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Details
11.6.2 Editas Medicine, Inc. Business Overview
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction
11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.6.5 Editas Medicine, Inc. Recent Development
11.7 Egenesis
11.7.1 Egenesis Company Details
11.7.2 Egenesis Business Overview
11.7.3 Egenesis CRISPR & Cas Genes Introduction
11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.7.5 Egenesis Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Details
11.9.2 Horizon Discovery Group Plc Business Overview
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction
11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2015-2020)
11.9.5 Horizon Discovery Group Plc Recent Development
11.10 Genscrip
11.10.1 Genscrip Company Details
11.10.2 Genscrip Business Overview
11.10.3 Genscrip CRISPR & Cas Genes Introduction
11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2015-2020)
11.10.5 Genscrip Recent Development
11.11 Danaher Corporation
10.11.1 Danaher Corporation Company Details
10.11.2 Danaher Corporation Business Overview
10.11.3 Danaher Corporation CRISPR & Cas Genes Introduction
10.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2015-2020)
10.11.5 Danaher Corporation Recent Development
11.12 Intellia Therapeutics, Inc.
10.12.1 Intellia Therapeutics, Inc. Company Details
10.12.2 Intellia Therapeutics, Inc. Business Overview
10.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction
10.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 Lonza
10.13.1 Lonza Company Details
10.13.2 Lonza Business Overview
10.13.3 Lonza CRISPR & Cas Genes Introduction
10.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2015-2020)
10.13.5 Lonza Recent Development
11.14 Merck KGaA
10.14.1 Merck KGaA Company Details
10.14.2 Merck KGaA Business Overview
10.14.3 Merck KGaA CRISPR & Cas Genes Introduction
10.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2015-2020)
10.14.5 Merck KGaA Recent Development
11.15 New England BioLabs
10.15.1 New England BioLabs Company Details
10.15.2 New England BioLabs Business Overview
10.15.3 New England BioLabs CRISPR & Cas Genes Introduction
10.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2015-2020)
10.15.5 New England BioLabs Recent Development
11.16 Takara Bio, Inc.
10.16.1 Takara Bio, Inc. Company Details
10.16.2 Takara Bio, Inc. Business Overview
10.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction
10.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.16.5 Takara Bio, Inc. Recent Development
11.17 Synthego
10.17.1 Synthego Company Details
10.17.2 Synthego Business Overview
10.17.3 Synthego CRISPR & Cas Genes Introduction
10.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2015-2020)
10.17.5 Synthego Recent Development
11.18 Mammoth Biosciences
10.18.1 Mammoth Biosciences Company Details
10.18.2 Mammoth Biosciences Business Overview
10.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction
10.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2015-2020)
10.18.5 Mammoth Biosciences Recent Development
11.19 Inscripta, Inc.
10.19.1 Inscripta, Inc. Company Details
10.19.2 Inscripta, Inc. Business Overview
10.19.3 Inscripta, Inc. CRISPR & Cas Genes Introduction
10.19.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.19.5 Inscripta, Inc. Recent Development
11.20 Cibus
10.20.1 Cibus Company Details
10.20.2 Cibus Business Overview
10.20.3 Cibus CRISPR & Cas Genes Introduction
10.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2015-2020)
10.20.5 Cibus Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
